Abstracts tagged "axial spondyloarthritis and clinical research"

Abstract Number: 703 • 2016 ACR/ARHP Annual Meeting
Performance of a New Spinal Mobility Index for Patients with Axial Spondyloarthritis
Graciela Betancur¹, Fernando Andres Sommerfleck², Ana Lizarraga¹, Natalia Zamora³, Maria Celeste Orozco³, Susana Gagliardi⁴, Emilce Schneeberger⁵ and Gustavo Citera⁵, ¹Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁴Rheumatology, Instituto de Rehabilitación Psicofísica, CABA, Argentina, ⁵Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: ASAS recommends using BASMI for evaluation of axial mobility in patients with Axial Spondyloarthritis (axSpA). The EDASMI (Edmonton Ankylosing Spondylitis Metrology Index) is another…
Abstract Number: 1735 • 2015 ACR/ARHP Annual Meeting
Imaging and Clinical Factors Associated with Subchondral Sacroiliac Fatty Marrow in Axial Spondyloarthritis
Kavi Devulapalli¹, Xenofon Baraliakos², Daria Motamedi¹ and Lianne S. Gensler³, ¹Radiology, UCSF, SAN FRANCISCO, CA, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: Magnetic resonance imaging (MR) plays an important role in the evaluation of inflammatory and structural changes in axial spondyloarthritis (axSpA) patients. Prior research suggests…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].